These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 25597706)

  • 1. Identification and characterization of a selective allosteric antagonist of human P2X4 receptor channels.
    Ase AR; Honson NS; Zaghdane H; Pfeifer TA; Séguéla P
    Mol Pharmacol; 2015 Apr; 87(4):606-16. PubMed ID: 25597706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbamazepine derivatives with P2X4 receptor-blocking activity.
    Tian M; Abdelrahman A; Weinhausen S; Hinz S; Weyer S; Dosa S; El-Tayeb A; Müller CE
    Bioorg Med Chem; 2014 Feb; 22(3):1077-88. PubMed ID: 24411477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P2X4 subunits are part of P2X native channels in murine myenteric neurons.
    Nieto-Pescador MG; Guerrero-Alba R; Valdez-Morales E; Espinosa-Luna R; Jiménez-Vargas N; Liñan-Rico Andrómeda A; Ramos-Lomas TL; Díaz-Hernández Verónica V; Montaño LM; Barajas-López C
    Eur J Pharmacol; 2013 Jun; 709(1-3):93-102. PubMed ID: 23567069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Allosteric Inhibitory Site Conserved in the Ectodomain of P2X Receptor Channels.
    Ase AR; Therrien É; Séguéla P
    Front Cell Neurosci; 2019; 13():121. PubMed ID: 31024257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P2X4 Receptor-Dependent Ca
    Layhadi JA; Fountain SJ
    Int J Mol Sci; 2017 Oct; 18(11):. PubMed ID: 29077063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the molecular determinants of antagonist potency in the allosteric binding pocket of human P2X4.
    Pasqualetto G; Zuanon M; Brancale A; Young MT
    Front Pharmacol; 2023; 14():1101023. PubMed ID: 36843952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATP Evokes Ca
    Layhadi JA; Turner J; Crossman D; Fountain SJ
    J Immunol; 2018 Feb; 200(3):1159-1168. PubMed ID: 29255078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of aurintricarboxylic acid as a potent allosteric antagonist of P2X1 and P2X3 receptors.
    Obrecht AS; Urban N; Schaefer M; Röse A; Kless A; Meents JE; Lampert A; Abdelrahman A; Müller CE; Schmalzing G; Hausmann R
    Neuropharmacology; 2019 Nov; 158():107749. PubMed ID: 31461640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of the inhibitory effects of the benzodiazepine derivative, 5-BDBD on P2X4 purinergic receptors by two complementary methods.
    Balázs B; Dankó T; Kovács G; Köles L; Hediger MA; Zsembery A
    Cell Physiol Biochem; 2013; 32(1):11-24. PubMed ID: 23867750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The phenothiazine-class antipsychotic drugs prochlorperazine and trifluoperazine are potent allosteric modulators of the human P2X7 receptor.
    Hempel C; Nörenberg W; Sobottka H; Urban N; Nicke A; Fischer W; Schaefer M
    Neuropharmacology; 2013 Dec; 75():365-79. PubMed ID: 23954492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based identification and characterisation of structurally novel human P2X7 receptor antagonists.
    Caseley EA; Muench SP; Fishwick CW; Jiang LH
    Biochem Pharmacol; 2016 Sep; 116():130-9. PubMed ID: 27481062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular binding sites of positive and negative allosteric P2X4 receptor modulators.
    Weinhausen S; Nagel J; Namasivayam V; Spanier C; Abdelrahman A; Hanck T; Hausmann R; Müller CE
    Life Sci; 2022 Dec; 311(Pt A):121143. PubMed ID: 36328074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural insights into the allosteric inhibition of P2X4 receptors.
    Shen C; Zhang Y; Cui W; Zhao Y; Sheng D; Teng X; Shao M; Ichikawa M; Wang J; Hattori M
    Nat Commun; 2023 Oct; 14(1):6437. PubMed ID: 37833294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lithocholic acid inhibits P2X2 and potentiates P2X4 receptor channel gating.
    Sivcev S; Slavikova B; Ivetic M; Knezu M; Kudova E; Zemkova H
    J Steroid Biochem Mol Biol; 2020 Sep; 202():105725. PubMed ID: 32652201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lidocaine preferentially inhibits the function of purinergic P2X7 receptors expressed in Xenopus oocytes.
    Okura D; Horishita T; Ueno S; Yanagihara N; Sudo Y; Uezono Y; Minami T; Kawasaki T; Sata T
    Anesth Analg; 2015 Mar; 120(3):597-605. PubMed ID: 25695577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural Basis of the Negative Allosteric Modulation of 5-BDBD at Human P2X4 Receptors.
    Bidula S; Nadzirin IB; Cominetti M; Hickey H; Cullum SA; Searcey M; Schmid R; Fountain SJ
    Mol Pharmacol; 2022 Jan; 101(1):33-44. PubMed ID: 34718224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tanshinone II A sulfonate, but not tanshinone II A, acts as potent negative allosteric modulator of the human purinergic receptor P2X7.
    Kaiser M; Sobottka H; Fischer W; Schaefer M; Nörenberg W
    J Pharmacol Exp Ther; 2014 Sep; 350(3):531-42. PubMed ID: 24970925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P2X4, P2Y1 and P2Y2 receptors on rat alveolar macrophages.
    Bowler JW; Bailey RJ; North RA; Surprenant A
    Br J Pharmacol; 2003 Oct; 140(3):567-75. PubMed ID: 12970084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of P2X4 function by P2Y6 UDP receptors in microglia.
    Bernier LP; Ase AR; Boué-Grabot É; Séguéla P
    Glia; 2013 Dec; 61(12):2038-49. PubMed ID: 24123515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purinergic P2X receptors: structural models and analysis of ligand-target interaction.
    Dal Ben D; Buccioni M; Lambertucci C; Marucci G; Thomas A; Volpini R
    Eur J Med Chem; 2015 Jan; 89():561-80. PubMed ID: 25462266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.